Yüklüyor......
Oxibendazole inhibits prostate cancer cell growth
Prostate cancer (PCa) is one of the most common malignancies among men and is the second leading cause of cancer-associated mortality in the developed world. Androgen deprivation therapy (ADT) is the most common treatment for PCa. However, the majority of androgen-sensitive PCa patients will eventua...
Kaydedildi:
| Yayımlandı: | Oncol Lett |
|---|---|
| Asıl Yazarlar: | , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
D.A. Spandidos
2018
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5776919/ https://ncbi.nlm.nih.gov/pubmed/29434928 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/ol.2017.7579 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|